Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diocare Cough Relief and Immune Health Soft Chews is a proprietary consumer health product in the Diocare line developed by Diomics in partnership with Bonne Santé Group as part of a broader COVID-19-era respiratory support portfolio. It is positioned as a nature-forward oral soft chew intended to provide symptomatic cough relief together with general immune health support. Publicly available information identified the product branding, developers, product positioning, and dosage form, but did not clearly disclose a verified ingredient composition, molecular targets, or a defined pharmacologic mechanism of action; accordingly, it is best characterized as a branded respiratory wellness supplement or nutraceutical product rather than a well-defined pharmaceutical agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diocare Cough Relief and Immune Health Soft Chews.